Presentations and updates
(SE) Redeye Investor Forum
View our latest presentation! Last week, Andreas represented Stayble Therapeutics at the Redeye Investor Forum. During the presentation, Andreas provided a detailed update on our latest developments and outlined the forthcoming plans and objectives….
View our latest presentation! Last week, Andreas represented Stayble Therapeutics at the Redeye Investor Forum. During the presentation, Andreas provided a detailed update on our latest developments and outlined the forthcoming plans and objectives….
(SE) Financial Stockholm 25/9
Stayble presented at Financial Stockholm’s investor meeting at Scandic Anglais in Stockholm, 25th of September. Our CEO, Andreas Gerward, shared insights about the Company’s latest progress, future plans, and how…
Stayble presented at Financial Stockholm’s investor meeting at Scandic Anglais in Stockholm, 25th of September. Our CEO, Andreas Gerward, shared insights about the Company’s latest progress, future plans, and how…
Inside Stayble: April 2021
In the April 2021 edition, CEO Andreas Gerward, discusses the ongoing clinical phase 2b, the recruitment of Sara Richardson in the newly created role VP CMC & Regulatory Affairs and…
In the April 2021 edition, CEO Andreas Gerward, discusses the ongoing clinical phase 2b, the recruitment of Sara Richardson in the newly created role VP CMC & Regulatory Affairs and…
Inside Stayble: February 2021
In the February 2021 edition, CEO Andreas Gerward, discusses the oversubscribed rights issue, next steps and partnering activities. Inside Stayble is a communication channel aiming to provide shareholders with monthly…
In the February 2021 edition, CEO Andreas Gerward, discusses the oversubscribed rights issue, next steps and partnering activities. Inside Stayble is a communication channel aiming to provide shareholders with monthly…
Inside Stayble: January 2021
In the January 2021 edition, CEO Andreas Gerward, gives a status report from the ongoing Phase 2b trial, current partnering activities and the upcoming rights issue. Inside Stayble is a…
In the January 2021 edition, CEO Andreas Gerward, gives a status report from the ongoing Phase 2b trial, current partnering activities and the upcoming rights issue. Inside Stayble is a…
Inside Stayble: December 2020
In the December 2020 edition, CEO Andreas Gerward, explains the upcoming rights issue more in-depth and reflects over 2020 and the upcoming 2021. Inside Stayble is a new communication channel…
In the December 2020 edition, CEO Andreas Gerward, explains the upcoming rights issue more in-depth and reflects over 2020 and the upcoming 2021. Inside Stayble is a new communication channel…
Inside Stayble: November 2020
In the November 2020 edition, CEO Andreas Gerward, explains the clinical phase IIb study with STA363 more in-depth and provides an overview of the company’s current affairs. Inside Stayble is a new communication channel aiming…
In the November 2020 edition, CEO Andreas Gerward, explains the clinical phase IIb study with STA363 more in-depth and provides an overview of the company’s current affairs. Inside Stayble is a new communication channel aiming…
BioStock Life Science Summit 2020
See CEO Andreas Gerward present at BioStock Life Science Summit 2020
See CEO Andreas Gerward present at BioStock Life Science Summit 2020
Inside Stayble: October 2020
In the October 2020 edition, CEO Andreas Gerward, covers the progress of the clinical phase IIb study with STA363, importance of participating in Eurospine congress, recruitment process of a CCO,…
In the October 2020 edition, CEO Andreas Gerward, covers the progress of the clinical phase IIb study with STA363, importance of participating in Eurospine congress, recruitment process of a CCO,…
Virtual presentation from LSX Nordic Congress Virtual 2020
Listen to CEO Andreas Gerward´s presentation at LSX Nordic Congress Virtual 2020.
Listen to CEO Andreas Gerward´s presentation at LSX Nordic Congress Virtual 2020.
